Dudediligence.

Personalis, Inc

PSNLNASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$25.7MSep ’24$16.8MDec ’24$20.6MMar ’25$17.2MJun ’25$14.5MSep ’25$17.3MDec ’25$15.5MMar ’26$22.4MJun ’26
Net income, by quarter
−$39.1MSep ’24−$16.4MDec ’24−$15.8MMar ’25−$20.1MJun ’25−$21.7MSep ’25−$23.8MDec ’25−$30.0MMar ’26−$31.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$85.5M$65.0M$73.5M$84.6M$69.6M
Gross profit$31.7M$13.3M$18.2M$26.8M$15.8M
Operating income−$65.4M−$115.5M−$109.9M−$68.3M−$88.1M
Net income−$65.2M−$113.3M−$108.3M−$81.3M−$81.3M
Operating cash flow−$70.8M−$70.2M−$56.3M−$45.1M−$74.9M
Free cash flow−$81.9M−$120.1M−$67.2M−$46.8M−$79.5M
Cash$105.6M$89.1M$57.0M$91.4M$124.2M
Shares outstanding44.9M46.7M50.5M85.2M102.5M